Burkholderia pseudomallei-induced Oligoarticular Septic Arthritis Masquerading as Tuberculosis in a Non-Diabetic Host
Ramesh Govindharaaju1, Raju Karuppal1, Khayas Omer Kunheen1
1Department of Orthopaedics, Government Medical College, Kozhikode, Kerala, India.
Introduction:
Burkholderia pseudomallei, the causative agent of melioidosis, is endemic in tropical and subtropical regions, primarily in Southeast Asia and northern Australia. Cases of septic arthritis caused by B. pseudomallei in India have rarely been reported and have been described mostly in diabetic patients. This case report outlines a case of oligoarticular septic arthritis in a non-diabetic patient with a previous history of extrapulmonary tuberculosis (TB).
Case Report:
A 62-year-old non-diabetic male receiving anti-tubercular therapy (ATT) for tubercular lymphadenitis presented with complaints of painful swelling of his left knee and right shoulder. Before consulting with us, he had undergone an arthrotomy and biopsy of his left knee at a different center. The biopsy was suggestive of granulomatous inflammation with negative cultures and acid-fast bacillus, for which he was advised to continue ATT for an extended duration. ATT did not improve his symptoms, and the patient developed a gradually progressing painful swelling of his right shoulder. At this point, he presented to us. Fresh cultures revealed B. pseudomallei as the causative organism. A strict regimen of intravenous ceftazidime followed by oral cotrimoxazole resulted in gradual recovery.
Conclusion:
Cases of B. pseudomallei-induced infective arthritis and systemic melioidosis are now being identified in India, probably as a result of increased cross-country travel. This case report describes oligoarticular septic arthritis in a non-diabetic patient, which is unique among similar cases in the literature. A previous history of TB and negative routine cultures confounded the diagnosis.
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...


